Expression of IL-13Ra2 gene in human brain tumors
Authors:
- 1 September 2005
- journal article
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 17 (3) , 157-160
Abstract
Objective: To investigate the expression of IL-13Ra2 gene in brain tumors. Methods: Seventy-nine human brain tumors were obtained from the department of Neurosurgery of China Medical University. Human IL-13Ra2 expression was evaluated by reverse transcriptase polymerase chain reaction and immunohistochemical analysis. Results: IL-13Ra2 gene was highly expressed in glioblastoma, medulloblastoma, malignant meningioma and benign meningioma. Conclusion: Human IL-13Ra2 gene is expressed in brain tumors in addition to gliomas, and our result indicates that the IL-13Ra2 gene promoter based gene therapy method can be used to treat brain tumors in addition to gliomas. Further studies involving larger numbers of samples are necessary to fully understand the expression profile of IL-13Ra2 gene in the brain tumors.Keywords
This publication has 11 references indexed in Scilit:
- Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoterNeuro-Oncology, 2003
- Molecular Cloning of the Rat IL-13 Alpha 2 Receptor CDNA and Its Expression in Rat TissuesJournal of Neuro-Oncology, 2002
- In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient MiceJournal of Experimental Medicine, 2001
- Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenograftsCancer Gene Therapy, 2001
- Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxinsCritical Reviews in Oncology/Hematology, 2001
- Interleukin-13 receptor as a unique target for anti-glioblastoma therapyInternational Journal of Cancer, 2001
- Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant gliomaCancer Immunology, Immunotherapy, 2000
- Expression of a Restrictive Receptor for Interleukin 13 is Associated with Glial TransformationJournal of Neuro-Oncology, 2000
- Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis AntigenMolecular Medicine, 2000
- Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α ChainJournal of Biological Chemistry, 1996